For researchers prioritizing regulatory certainty, real-world safety data, and established protocols, Tirzepatide remains the gold standard in the GLP-1 agonist class as of 2026
CJC-1295 and Ipamorelin are currently on the FDAs compounding restriction list
Wei Xu, Qingdao University Medical College, China Updates Copyright 2023 Huguenard, Cseresznye, Darcey, Nkiliza, Evans, Hazen, Mullan, Crawford and Abdullah
Semaglutide for managing overweight and obesity TA875, Chapter 1: Recommendations
This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License ( which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
It is well established that in the apo-state the ECD also forms a close interaction with the TMD and this interaction inhibits receptor activation, because mutations in the ECL3 residues of the calcitonin gene-related peptide receptor and GCGR have resulted in significant increases in both basal and ligand-induced activity [4144]